Seek Returns logo

DHR vs. MTD: A Head-to-Head Stock Comparison

Updated on

Here’s a clear look at DHR and MTD, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

SymbolDHRMTD
Company NameDanaher CorporationMettler-Toledo International Inc.
CountryUnited StatesUnited States
GICS SectorHealth CareHealth Care
GICS IndustryLife Sciences Tools & ServicesLife Sciences Tools & Services
Market Capitalization151.37 billion USD27.13 billion USD
ExchangeNYSENYSE
Listing DateDecember 29, 1978November 14, 1997
Security TypeCommon StockCommon Stock

Historical Performance

This chart compares the performance of DHR and MTD by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

DHR vs. MTD: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

SymbolDHRMTD
5-Day Price Return0.56%0.25%
13-Week Price Return7.63%13.61%
26-Week Price Return3.84%1.52%
52-Week Price Return-22.07%-8.22%
Month-to-Date Return7.22%6.74%
Year-to-Date Return-7.91%7.62%
10-Day Avg. Volume3.11M0.15M
3-Month Avg. Volume4.00M0.19M
3-Month Volatility26.58%28.76%
Beta0.791.40

Profitability

Return on Equity (TTM)

DHR

6.69%

Life Sciences Tools & Services Industry

Max
19.96%
Q3
11.55%
Median
6.22%
Q1
3.86%
Min
-6.95%

DHR’s Return on Equity of 6.69% is on par with the norm for the Life Sciences Tools & Services industry, indicating its profitability relative to shareholder equity is typical for the sector.

MTD

1,675.84%

Life Sciences Tools & Services Industry

Max
19.96%
Q3
11.55%
Median
6.22%
Q1
3.86%
Min
-6.95%

MTD’s Return on Equity of 1,675.84% is exceptionally high, placing it well beyond the typical range for the Life Sciences Tools & Services industry. This demonstrates a superior ability to generate profit from shareholder investments, though it could also be inflated by high financial leverage.

DHR vs. MTD: A comparison of their Return on Equity (TTM) against the Life Sciences Tools & Services industry benchmark.

Net Profit Margin (TTM)

DHR

14.21%

Life Sciences Tools & Services Industry

Max
27.28%
Q3
16.17%
Median
7.24%
Q1
3.00%
Min
-3.05%

DHR’s Net Profit Margin of 14.21% is aligned with the median group of its peers in the Life Sciences Tools & Services industry. This indicates its ability to convert revenue into profit is typical for the sector.

MTD

21.46%

Life Sciences Tools & Services Industry

Max
27.28%
Q3
16.17%
Median
7.24%
Q1
3.00%
Min
-3.05%

A Net Profit Margin of 21.46% places MTD in the upper quartile for the Life Sciences Tools & Services industry, signifying strong profitability and more effective cost management than most of its peers.

DHR vs. MTD: A comparison of their Net Profit Margin (TTM) against the Life Sciences Tools & Services industry benchmark.

Operating Profit Margin (TTM)

DHR

18.43%

Life Sciences Tools & Services Industry

Max
33.15%
Q3
19.34%
Median
13.02%
Q1
8.05%
Min
-4.38%

DHR’s Operating Profit Margin of 18.43% is around the midpoint for the Life Sciences Tools & Services industry, indicating that its efficiency in managing core business operations is typical for the sector.

MTD

26.49%

Life Sciences Tools & Services Industry

Max
33.15%
Q3
19.34%
Median
13.02%
Q1
8.05%
Min
-4.38%

An Operating Profit Margin of 26.49% places MTD in the upper quartile for the Life Sciences Tools & Services industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.

DHR vs. MTD: A comparison of their Operating Profit Margin (TTM) against the Life Sciences Tools & Services industry benchmark.

Profitability at a Glance

SymbolDHRMTD
Return on Equity (TTM)6.69%1,675.84%
Return on Assets (TTM)4.28%25.15%
Net Profit Margin (TTM)14.21%21.46%
Operating Profit Margin (TTM)18.43%26.49%
Gross Profit Margin (TTM)59.72%59.94%

Financial Strength

Current Ratio (MRQ)

DHR

1.62

Life Sciences Tools & Services Industry

Max
4.76
Q3
2.77
Median
1.85
Q1
1.40
Min
0.43

DHR’s Current Ratio of 1.62 aligns with the median group of the Life Sciences Tools & Services industry, indicating that its short-term liquidity is in line with its sector peers.

MTD

1.12

Life Sciences Tools & Services Industry

Max
4.76
Q3
2.77
Median
1.85
Q1
1.40
Min
0.43

MTD’s Current Ratio of 1.12 falls into the lower quartile for the Life Sciences Tools & Services industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.

DHR vs. MTD: A comparison of their Current Ratio (MRQ) against the Life Sciences Tools & Services industry benchmark.

Debt-to-Equity Ratio (MRQ)

DHR

0.33

Life Sciences Tools & Services Industry

Max
1.75
Q3
0.83
Median
0.41
Q1
0.18
Min
0.00

DHR’s Debt-to-Equity Ratio of 0.33 is typical for the Life Sciences Tools & Services industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.

MTD

81.23

Life Sciences Tools & Services Industry

Max
1.75
Q3
0.83
Median
0.41
Q1
0.18
Min
0.00

With a Debt-to-Equity Ratio of 81.23, MTD operates with exceptionally high leverage compared to the Life Sciences Tools & Services industry norm. This suggests an aggressive reliance on debt financing, which can magnify returns but also significantly elevates financial risk.

DHR vs. MTD: A comparison of their Debt-to-Equity Ratio (MRQ) against the Life Sciences Tools & Services industry benchmark.

Interest Coverage Ratio (TTM)

DHR

22.31

Life Sciences Tools & Services Industry

Max
29.61
Q3
23.24
Median
6.07
Q1
2.18
Min
-14.08

DHR’s Interest Coverage Ratio of 22.31 is positioned comfortably within the norm for the Life Sciences Tools & Services industry, indicating a standard and healthy capacity to cover its interest payments.

MTD

15.60

Life Sciences Tools & Services Industry

Max
29.61
Q3
23.24
Median
6.07
Q1
2.18
Min
-14.08

MTD’s Interest Coverage Ratio of 15.60 is positioned comfortably within the norm for the Life Sciences Tools & Services industry, indicating a standard and healthy capacity to cover its interest payments.

DHR vs. MTD: A comparison of their Interest Coverage Ratio (TTM) against the Life Sciences Tools & Services industry benchmark.

Financial Strength at a Glance

SymbolDHRMTD
Current Ratio (MRQ)1.621.12
Quick Ratio (MRQ)1.100.67
Debt-to-Equity Ratio (MRQ)0.3381.23
Interest Coverage Ratio (TTM)22.3115.60

Growth

Revenue Growth

DHR vs. MTD: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

DHR vs. MTD: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

DHR

0.54%

Life Sciences Tools & Services Industry

Max
1.80%
Q3
0.78%
Median
0.37%
Q1
0.00%
Min
0.00%

DHR’s Dividend Yield of 0.54% is consistent with its peers in the Life Sciences Tools & Services industry, providing a dividend return that is standard for its sector.

MTD

0.00%

Life Sciences Tools & Services Industry

Max
1.80%
Q3
0.78%
Median
0.37%
Q1
0.00%
Min
0.00%

MTD currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

DHR vs. MTD: A comparison of their Dividend Yield (TTM) against the Life Sciences Tools & Services industry benchmark.

Dividend Payout Ratio (TTM)

DHR

23.85%

Life Sciences Tools & Services Industry

Max
156.00%
Q3
65.73%
Median
23.81%
Q1
0.00%
Min
0.00%

DHR’s Dividend Payout Ratio of 23.85% is within the typical range for the Life Sciences Tools & Services industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

MTD

0.00%

Life Sciences Tools & Services Industry

Max
156.00%
Q3
65.73%
Median
23.81%
Q1
0.00%
Min
0.00%

MTD has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.

DHR vs. MTD: A comparison of their Dividend Payout Ratio (TTM) against the Life Sciences Tools & Services industry benchmark.

Dividend at a Glance

SymbolDHRMTD
Dividend Yield (TTM)0.54%0.00%
Dividend Payout Ratio (TTM)23.85%0.00%

Valuation

Price-to-Earnings Ratio (TTM)

DHR

44.40

Life Sciences Tools & Services Industry

Max
117.96
Q3
65.59
Median
37.26
Q1
27.51
Min
1.73

DHR’s P/E Ratio of 44.40 is within the middle range for the Life Sciences Tools & Services industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.

MTD

32.53

Life Sciences Tools & Services Industry

Max
117.96
Q3
65.59
Median
37.26
Q1
27.51
Min
1.73

MTD’s P/E Ratio of 32.53 is within the middle range for the Life Sciences Tools & Services industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.

DHR vs. MTD: A comparison of their Price-to-Earnings Ratio (TTM) against the Life Sciences Tools & Services industry benchmark.

Price-to-Sales Ratio (TTM)

DHR

6.31

Life Sciences Tools & Services Industry

Max
12.46
Q3
6.70
Median
4.24
Q1
2.68
Min
0.73

DHR’s P/S Ratio of 6.31 aligns with the market consensus for the Life Sciences Tools & Services industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.

MTD

6.98

Life Sciences Tools & Services Industry

Max
12.46
Q3
6.70
Median
4.24
Q1
2.68
Min
0.73

MTD’s P/S Ratio of 6.98 is in the upper echelon for the Life Sciences Tools & Services industry. This means the company is valued richly on its revenue stream compared to its peers, suggesting the stock is priced for a high level of future performance.

DHR vs. MTD: A comparison of their Price-to-Sales Ratio (TTM) against the Life Sciences Tools & Services industry benchmark.

Price-to-Book Ratio (MRQ)

DHR

2.72

Life Sciences Tools & Services Industry

Max
7.99
Q3
4.69
Median
3.30
Q1
1.88
Min
1.02

DHR’s P/B Ratio of 2.72 is within the conventional range for the Life Sciences Tools & Services industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.

MTD

1,299.40

Life Sciences Tools & Services Industry

Max
7.99
Q3
4.69
Median
3.30
Q1
1.88
Min
1.02

At 1,299.40, MTD’s P/B Ratio is at an extreme premium to the Life Sciences Tools & Services industry. This signifies that the market’s valuation is heavily reliant on future potential rather than its current net asset value, which can be a high-risk proposition.

DHR vs. MTD: A comparison of their Price-to-Book Ratio (MRQ) against the Life Sciences Tools & Services industry benchmark.

Valuation at a Glance

SymbolDHRMTD
Price-to-Earnings Ratio (TTM)44.4032.53
Price-to-Sales Ratio (TTM)6.316.98
Price-to-Book Ratio (MRQ)2.721,299.40
Price-to-Free Cash Flow Ratio (TTM)31.1731.84